Mohamed Hassan Elkaseer

Mohamed Hassan Elkaseer

Auto-generated profile, based on publicly available information

Mohamed Hassan Elkaseer

General Surgery Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
AEAbduh Elbanna
Abduh Elbanna
ASAhmed Abd El Aal Sultan
Ahmed Abd El Aal Sultan
YAYasser Helmy Ali
Yasser Helmy Ali
IBIbrahim Bakr
Ibrahim Bakr
MEMohamed Tag El-Din
Mohamed Tag El-Din
MSMohamed Sobhy Shaaban
Mohamed Sobhy Shaaban
Background: Obesity is a chronic condition that affects millions globally; consequently, bariatric surgery is the key to this serious issue. Bariatric procedures are rapidly expanding in number and methods to address the recognized problems. So, it would make a sense for surgeons and patients if there is a more physiological bypass surgery technique in Morbid obesity. This study aims to evaluate the outcome proposed technique. Patients and methods: The present study is a retrospective analysis on 256 participants subjected to the proposed bypass procedure from December 1999 to January 2017, the participants were followed up for an interval of 3years. Results: The findings of the present study revealed a significant Excess Weight Loss (EWL). In addition, patients experienced decreased calcium, iron, vitamin B12, Hemoglobin, zinc, and Prothrombin Concentration. However, three to six months after surgery, they experienced a significant improvement until they reached normal levels without any supplement by the end of 12,18 months, with a three-year follow-up. Conclusion: This proposed Bypass Operation aims to adequate digestions as well as selective absorption without inducing any vital deficit. Most of study's population showed no elements inadequacies, although few percentages emerged during the interval of maximal weight reduction, and it were transient and minimal. No minerals or vitamins were needed.

1 January 2022 in The Egyptian Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
MEMohamed Hasan Mohamed Elkaseer
Mohamed Hasan Mohamed Elkaseer
Background: Obesity is often associated with multiple negative health-related comorbidities. There is an increased risk of sexual dysfunction in the obese population. Although multiple studies reported significant improvement of these complaints after different bariatric surgeries, there are few studies evaluating the role of laparoscopic sleeve gastrectomy (LSG) on this specific outcome. Objective: This study was conducted to evaluate the effect of LSG on sexual function in male patients with morbid obesity. Patients and methods: This prospective study included 114 morbid obese patients with erectile dysfunction (ED). All patients underwent the conventional LSG. Sexual function was evaluated using the International Index of Erectile Function (IIEF) score before surgery, then after six and 12 months after surgery. The severity of ED was evaluated according to the erectile function component of the same previous score. Results: The one-year % of excess weight loss (EWL) had a mean value of 61.18%. At the same visit, there was a significant improvement in the total IIEF score from 49.04 to 67.88, erectile function from 18.25 to 25.94, orgasm function from 6.99 to 9.41, sexual desire from 7.06 to 9.35, intercourse satisfaction from 9.25 to 13.56, and overall satisfaction from 7.49 to 9.61. A significant positive association was noted between the % EWL and the total IIEF score and its components. Conclusion: LSG led to significant improvement of sexual and erectile dysfunction in obese male patients. Weight loss led to a significant decline in the prevalence of ED, and if the problem did not resolve, its severity would be markedly decreased.

22 November 2021 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ASAhmed Salman
Ahmed Salman
MMMohamed Matter
Mohamed Matter
NFNabil Ibrahim Fayad
Nabil Ibrahim Fayad
MSMohamed S. Abd Elaziz Shehata
Mohamed S. Abd Elaziz Shehata
MAMohamed Abd Al-Fattah
Mohamed Abd Al-Fattah
HAHazem Abd Allah Ali
Hazem Abd Allah Ali

14 January 2022 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ASAhmed Salman
Ahmed Salman
MMMohamed Matter
Mohamed Matter
NFNabil Ibrahim Fayad
Nabil Ibrahim Fayad
MSMohamed S. Abd Elaziz Shehata
Mohamed S. Abd Elaziz Shehata
MAMohamed Abd Al-Fattah
Mohamed Abd Al-Fattah
HAHazem Abd Allah
Hazem Abd Allah

1 January 2022 in The Egyptian Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
MEMohamed Hasan Mohamed Elkaseer
Mohamed Hasan Mohamed Elkaseer
Background: Performing cholecystectomy concomitant to laparoscopic sleeve gastrectomy (LSG) in morbidly obese patients with asymptomatic cholelithiasis is poorly discussed. Objectives: We conducted the current investigation to compare concomitant to late cholecystectomy in asymptomatic gall stone patients undergoing LSG. Patients and methods: One hundred morbid obese patients scheduled for LSG were included in this retrospective analysis. They were divided into two groups: Group 1 included patients who underwent concomitant cholecystectomy, and group 2 that included patients who omitted such a procedure. Delayed cholecystectomy was scheduled if the patient developed symptoms related to gall bladder disease. The incidence of post-operative complications and percentage of developing symptomatic cholelithiasis in group 2 were our outcomes. Results: All preoperative data were statistically comparable between the two groups. However, operative time and intraoperative blood loss were significantly increased in group 1. The incidence of total early post-operative complications also increased in the same group (14% vs 0% in the other group). In Group 1, we encountered two patients with intraperitoneal bleeding (4%) who required laparoscopic management, in addition to the other two cases with biliary leakage (4%). In group 2, 18% of patients expressed symptomatic gall stone disease before the scheduled operation, while two cases (4%) developed acute complications that required early cholecystectomy. Conclusion: Cholecystectomy is associated with an increased incidence of early post-operative complications when performed in association with LSG. However, about 25% of asymptomatic cases who omitted the concomitant procedure will develop symptoms before the scheduled cholecystectomy.

1 January 2026 in Qatar Medical Journal
Verified
Journal Article
Open access
AAAyman Abdulmohaymen
Ayman Abdulmohaymen
SASayed R. Abdelbary
Sayed R. Abdelbary
TATamer A. Abouelgreed
Tamer A. Abouelgreed
ASAbd El-Fattah Al Sheikh
Abd El-Fattah Al Sheikh
HEHany El-Hady
Hany El-Hady
Ahmed LameyAhmed Lamey
Ahmed Lamey
Background: Superficial parotidectomy is the traditional treatment for benign parotid tumors but may be associated with facial nerve dysfunction and other morbidities. Intracapsular parotidectomy has emerged as a function-preserving alternative; however, concerns regarding oncologic safety remain. Randomized evidence comparing both techniques is limited. Therefore, this study aimed to compare their functional and oncologic outcomes. Objective: This study aimed to compare intracapsular parotidectomy and superficial parotidectomy in terms of operative efficiency, complications, facial nerve preservation, and tumor recurrence for benign parotid tumors. Methodology: This multicenter randomized controlled trial included patients with benign parotid tumors who were randomly assigned to undergo either intracapsular or superficial parotidectomy between May 2019 and May 2023, in Cairo, Egypt. Functional outcomes, postoperative complications, and recurrence rates were evaluated. Results: The mean age was 46.3 ± 9.5 years, with a range of 25–65 years. Most patients (84, 70%) were male, while 36 (30%) were female. The intracapsular parotidectomy (ICP) group demonstrated significantly reduced operative time (68.5 ± 12.3 vs. 88.3 ± 14.5 minutes; p = 0.01) and blood loss (120 ± 55.3 vs. 170 ± 50.5 ml; p = 0.001) compared to the superficial parotidectomy (SP) group. Facial nerve injury occurred exclusively in the SP group 9 (15%), including 3 (5%) cases of permanent palsy. Recurrence was observed in 1 (1.7%) ICP case and 3 (5%) SP cases, with no statistically significant difference ( p > 0.05). Other complications, including seroma formation and postoperative bleeding, were similarly distributed between the two groups. Conclusion: Intracapsular parotidectomy is a safe, effective, and less invasive alternative to superficial parotidectomy for benign parotid tumors. It offers shorter operative time, reduced bleeding, and improved facial nerve preservation without compromising oncological outcomes. Careful patient selection is essential for optimal results.